Whole-exome tumor sequencing in this patient revealed a somatic nonsense mutation (Q1178*) in the tumor-suppressor gene TSC2 that inactivates the gene, allowing for activation of the mTOR pathway [52]. The gene discussed is MTOR; the disease is neoplasm.